DNA Cloning, Characterization, and Inhibition Studies of an α-Carbonic Anhydrase from the Pathogenic Bacterium Vibrio cholerae

2012 ◽  
Vol 55 (23) ◽  
pp. 10742-10748 ◽  
Author(s):  
Sonia Del Prete ◽  
Semra Isik ◽  
Daniela Vullo ◽  
Viviana De Luca ◽  
Vincenzo Carginale ◽  
...  
2013 ◽  
Vol 23 (6) ◽  
pp. 1636-1638 ◽  
Author(s):  
Daniela Vullo ◽  
Semra Isik ◽  
Sonia Del Prete ◽  
Viviana De Luca ◽  
Vincenzo Carginale ◽  
...  

2016 ◽  
Vol 24 (5) ◽  
pp. 1115-1120 ◽  
Author(s):  
Sonia Del Prete ◽  
Daniela Vullo ◽  
Viviana De Luca ◽  
Vincenzo Carginale ◽  
Marta Ferraroni ◽  
...  

2016 ◽  
Vol 26 (5) ◽  
pp. 1406-1410 ◽  
Author(s):  
Daniela Vullo ◽  
Sonia Del Prete ◽  
Viviana De Luca ◽  
Vincenzo Carginale ◽  
Marta Ferraroni ◽  
...  

2018 ◽  
Vol 77 ◽  
pp. 1-5 ◽  
Author(s):  
Andrea Angeli ◽  
Sonia Del Prete ◽  
William A. Donald ◽  
Clemente Capasso ◽  
Claudiu T. Supuran

2007 ◽  
Vol 50 (2) ◽  
pp. 381-388 ◽  
Author(s):  
Isao Nishimori ◽  
Tomoko Minakuchi ◽  
Saburo Onishi ◽  
Daniela Vullo ◽  
Andrea Scozzafava ◽  
...  

2013 ◽  
Vol 29 (1) ◽  
pp. 23-27 ◽  
Author(s):  
Sonia Del Prete ◽  
Viviana De Luca ◽  
Andrea Scozzafava ◽  
Vincenzo Carginale ◽  
Claudiu T. Supuran ◽  
...  

2020 ◽  
Vol 21 (9) ◽  
pp. 3131
Author(s):  
Kübra Demir-Yazıcı ◽  
Özlen Güzel-Akdemir ◽  
Andrea Angeli ◽  
Claudiu T. Supuran ◽  
Atilla Akdemir

Due to the increasing resistance of currently used antimicrobial drugs, there is an urgent problem for the treatment of cholera disease, selective inhibition of the α-class carbonic anhydrases (CA, EC 4.2.1.1) from the pathogenic bacterium Vibrio cholerae (VcCA) presents an alternative therapeutic target. In this study, a series of hydrazone derivatives, carrying the 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide scaffold, have been evaluated as inhibitors of the VcCA with molecular modeling studies. The results suggest that these compounds may bind to the active site of VcCA. To verify this, VcCA enzyme inhibition studies were performed and as predicted most of the tested compounds displayed potent inhibitory activities against VcCA with three compounds showing KI values lower than 30 nM. In addition, all these compounds showed selectivity for VcCA and the off-targets hCA I and II.


2020 ◽  
Vol 0 (0) ◽  
Author(s):  
Muhammad Imran ◽  
Ahmad Irfan ◽  
Mohammed A. Assiri ◽  
Sajjad H. Sumrra ◽  
Muhammad Saleem ◽  
...  

AbstractThe Aerva plants are exceptionally rich in phytochemicals and possess therapeutics potential. Phytochemical screening shows that Aerva persica (Burm.f.) Merr. contains highest contents i.e., total phenolics, flavonoids, flavonols, tannins, alkaloids, carbohydrates, anthraquinones and glycosides. In-vitro antibacterial and enzymatic (carbonic anhydrase) inhibition studies on methanol extracts of A. persica indicated the presence of biological active constituents within chloroform soluble portions. Investigation in the pure constituents on the chloroform portions of A. persica accomplished by column chromatography, NMR and MS analysis. The bioguided isolation yields four chemical constituents of coumaronochromone family, namely aervin (1-4). These pure chemical entities (1-4) showed significant antibacterial activity in the range of 60.05–79.21 µg/ml against various bacterial strains using ampicillin and ciprofloxacin as standard drugs. The compounds 1-4 showed promising carbonic anhydrase inhibition with IC50 values of 19.01, 18.24, 18.65 and 12.92 µM, respectively, using standard inhibitor acetazolamide. First-principles calculations revealed comprehensive intramolecular charge transfer in the studied compounds 1-4. The spatial distribution of highest occupied and lowest unoccupied molecular orbitals, ionization potential, molecular electrostatic potential and Hirshfeld analysis revealed that these coumaronochromone compounds would be proficient biological active compounds. These pure constituents may be used as a new pharmacophore to treat leaukomia, epilepsy, glaucoma and cystic fibrosis.


2021 ◽  
Vol 36 (1) ◽  
pp. 372-376
Author(s):  
Andrea Petreni ◽  
Viviana De Luca ◽  
Andrea Scaloni ◽  
Alessio Nocentini ◽  
Clemente Capasso ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document